Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma.

J Immunol Res · 2022 · PMC9273399 · PMID 35832648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

However, there may be significant differences in prognosis even in patients with the same TNM staging and pathological grade after similar treatment [ 7 , 8 ], indicating that KIRC is a heterogeneous tumor, and the existing clinicopathological features and classification are not sufficient to evaluate the prognosis and risk stratification of KIRC patients.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.